The BTD gene gives your body instructions to make biotinidase, an enzyme that recycles biotin, a B vitamin your cells need to use fats, sugars, and proteins for energy and growth. Many people first learn about this gene when newborn screening suggests biotinidase deficiency. If the gene does not work well, biotin can become too low, which may lead to seizures, low muscle tone, skin rash, hair loss, hearing loss, vision problems, or developmental delay. Early treatment with biotin can help prevent many symptoms.
What is a gene?
A gene is a section of DNA that gives your cells instructions they use to make molecules or regulate processes in the body. Some genes contain the code for proteins, the parts of cells that do much of the work. Others are mainly involved in controlling when certain processes happen, where they occur, and how strongly they are active. Taken together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. To explore this subject in more detail, you can learn more in LearnHub.
Overview
BTDGene function
What if the gene works
The BTD gene helps your body recycle biotin, a B vitamin also called vitamin B7. This supports enzymes that help process fats, sugars, and proteins.
Risk
What if the gene does not work
More severe variants in the BTD gene can cause biotinidase deficiency, which may lead to seizures, low muscle tone, developmental delay, skin rash, and hearing or vision loss. Milder variants often cause partial deficiency with later, less pronounced symptoms.
Treatment
What does that mean for your treatment
Pathogenic variants in the BTD gene have a clear treatment implication: standard care is lifelong oral biotin, which can prevent symptoms when started early and often improves control if symptoms are already present. People with partial loss of biotinidase activity may also be treated with biotin, with the exact plan guided by residual enzyme activity and clinical follow-up.
Conditions associated with BTD
Gene function
What if the gene works
The BTD gene helps your body reuse biotin, a B vitamin also called vitamin B7. This matters every day because biotin supports enzymes that help process fats, carbohydrates, and certain protein building blocks. Understanding BTD gene function makes it easier to see how your body recovers and reuses this vitamin instead of wasting it.
The BTD gene provides instructions for biotinidase, an enzyme that frees biotin so your body can use it again. This recycling step helps maintain a steady supply of biotin during normal cell activity.
Biotinidase also helps release biotin from biotin attached to proteins and small protein pieces. That gives your body free biotin that can be reused in everyday metabolism.
By keeping biotin available, the BTD gene supports several enzymes that rely on this vitamin to work properly. These enzymes help your body handle routine tasks such as using fats, carbohydrates, and some amino acids.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help account for normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can affect a gene’s function more strongly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
BTD gene variants can lower the amount of working biotinidase enzyme by changing its shape, making it unstable, or disrupting splicing (how the cell edits the gene message). This is how BTD gene variants affect biotinidase activity: some leave partial enzyme function, while more severe variants leave very little or none. That difference in residual activity can influence whether biotinidase deficiency is partial or profound, and may affect how early or how strongly features appear.
How variants are linked to conditions
Pathogenic variants in the BTD gene cause biotinidase deficiency, a genetic condition often found on newborn screening. If untreated, severe forms can lead to seizures, low muscle tone, developmental delay, hearing loss, vision problems, skin rash, or hair loss. Partial biotinidase deficiency is usually milder but can still cause symptoms during illness or other physical stress. BTD gene variants linked to biotinidase deficiency can confirm the diagnosis when both gene copies are affected.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology, and they are common throughout the general population. Most do not have a direct effect on health and instead are part of normal human variation. For many genes, having a variant associated with a condition indicates a possible association rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For the BTD gene, risk is mainly shaped by inheritance: a child is affected when both parents pass down a changed copy, so family history and parents who are related by blood can raise the chance. Once someone has biotinidase deficiency, the main way to prevent illness and complications is regular biotin treatment, rather than lifestyle changes.
Inheritance of BTD variants
BTD-related biotinidase deficiency is inherited in an autosomal recessive pattern. In practical terms, how variants of the BTD gene are inherited usually means a child needs to receive one altered copy from each parent to have the condition. When both parents carry a BTD gene variant, each pregnancy has a 25% chance of biotinidase deficiency, a 50% chance of carrier status, and a 25% chance of inheriting neither variant. Because the BTD gene is on chromosome 3, sons and daughters are affected at similar rates.
What does my BTD result mean for my family?
For families with a BTD-related condition, close relatives may also be carriers, even if they feel completely well. Brothers and sisters could also have the condition or carry the gene change, so the result can matter beyond one person. Parents are usually carriers, and other family members may want to learn whether the same change runs in the family.
Genetic information
Genetic testing
How you find out about variants
BTD genetic testing looks for changes in the BTD gene, usually from a small blood sample or saliva sample. A lab reads the gene’s DNA sequence to check for variants linked with biotinidase deficiency, helping clarify whether a person has the condition or carries a variant that could be passed on in a family.
When should I consider getting a genetic test?
Consider BTD testing if a newborn screening suggests biotinidase deficiency, if there is a family history, or if someone has signs such as seizures, low muscle tone, skin rash, hair loss, hearing loss, or developmental delays. Testing can confirm the cause and guide early treatment with biotin.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but the amount they explain depends on the condition and on the kind of variant involved. How your body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic finding can give a clear answer. In areas like medication response, genetic results may help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines because the body does not handle every drug in exactly the same way. Some people break down a medicine faster or more slowly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, have less benefit for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics looks at how differences in genes can shape a person’s response to medication. It examines gene-drug relationships to better explain why the same treatment may work differently from one person to another. For many medicines, genes can affect either how strongly a drug works or how the body processes it. This information can help support more informed and more individualized treatment decisions. More about this topic is available in the LearnHub.
Drugs influenced by the BTD gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. For questions about side effects, supplements, or how a health condition may affect treatment, talk with your doctor or pharmacist.
History
Biotinidase deficiency came to medical attention in the early 1980s, when researchers recognized a treatable inherited condition behind symptoms such as seizures, skin rash, and hair loss in some infants and children. Initially understood through clinical findings and low enzyme activity, it was later linked to the BTD gene. From these first observations, research expanded steadily. By the 1980s and 1990s, studies showed that early diagnosis and biotin treatment could change outcomes, which helped support newborn screening programs in many countries. The BTD gene was identified in the 1990s, allowing more precise genetic confirmation in affected families. This history made biotinidase deficiency an important example of how genetic discovery can support early treatment and prevention of symptoms.